Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Crossover, Double-blind, Phase 2 Study of AD981 Versus Placebo in Obesity Hypoventilation Syndrome

NCT05448443 is registered in ClinicalTrials.gov with Istituto Auxologico Italiano as lead sponsor.

NCT NCT05448443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05448443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Crossover, Double-blind, Phase 2 Study of AD981 Versus Placebo in Obesity Hypoventilation Syndrome
Lead sponsor
Istituto Auxologico Italiano
Phase
Phase 2
Overall status
Completed
Start date
June 21, 2022
Completion date
May 8, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity hypoventilation syndrome (ohs)